Brief: Evonik Reports Q3 Sales At €3.83 Bln
BRIEF-Evonik Reports Q3 Sales At €3.83 Bln Nov 3 (Reuters) - EVONIK INDUSTRIES AG EVKn.DE:
Q3 ADJUSTED EBITDA AT €629 MILLION, UP 40% Y-O-Y
Q3 SALES AT €3.83 BILLION, UP 13% Y-O-Y
OUTLOOK 2026: SEES ADJUSTED EBITDA IN UPPER HALF OF €2.0 BILLION-€2.2 BILLION RANGE
PREPARATIONS FOR POSSIBLE SALE OF SYNEQT HAVE STARTED
EXPECTS EARNINGS TO INCREASE IN Q4 COMPARED TO SAME PERIOD LAST YEAR
OXENO SALE PROCESS IS PROGRESSING ACCORDING TO PLAN; BUYER TO BE ANNOUNCED IN COMING MONTHS
Further company coverage: [EVKn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Evonik Industries AG
See all newsEuropean industry calls for changes to carbon reform to avoid more factory closures
Europe chemicals downturn likely to spur more mergers, Lanxess CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
Brief: Evonik Invests €52 Mln To Expand Silicone Platform In Essen